Rundquist S, Sachs MC, Eriksson C, Olen O, et al. Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply. Aliment Pharmacol Ther 2021;53:642-643.
PMID: 33566420